acute myeloid leukemia

Showing NaN - NaN of 91

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Acute Myeloid Leukemia Trial in Boston (MLN9708, Cytarabine, Daunorubicin)

Recruiting
  • Acute Myeloid Leukemia
  • Boston, Massachusetts
    Massachusetts General Hospital
Jan 18, 2021

Acute Lymphocytic Leukemia, Acute Myeloid Leukemia, Non-Hodgkin Lymphoma Trial in Boston (iThermonitor)

Completed
  • Acute Lymphocytic Leukemia
  • +2 more
  • iThermonitor
  • Boston, Massachusetts
    Amanda Centi
Sep 27, 2020

Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, Myelodysplastic Syndrome-Refractory Anemia With Excess Blasts Trial in

Completed
  • Acute Myeloid Leukemia
  • +2 more
  • GM-K562/leukemia cell vaccine
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Sep 15, 2020

Acute Myeloid Leukemia Trial in Boston (Regorafenib)

Active, not recruiting
  • Acute Myeloid Leukemia
  • Boston, Massachusetts
    Massachusetts general Hospital
Sep 4, 2020

MDS, Chronic Myelomonocytic Leukemia, Acute Myeloid Leukemia Trial in Worldwide (Panobinostat (LBH589), 5-Azacytidine)

Completed
  • Myelodysplastic Syndromes
  • +2 more
  • Augusta, Georgia
  • +37 more
Jul 20, 2020

Acute Myeloid Leukemia Trial in Boston (Alisertib, Cytarabine, Idarubicin)

Completed
  • Acute Myeloid Leukemia
  • Boston, Massachusetts
  • +1 more
Apr 23, 2020

Blastic Plasmacytoid Dendritic Cell Tumor (BPDCN), Acute Myeloid Leukemia Trial in United States (SL-401)

Completed
  • Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
  • Acute Myeloid Leukemia
  • Duarte, California
  • +8 more
Apr 6, 2020

Acute Myeloid Leukemia Trial in Worldwide (PF-04449913, Low dose ARA-C (LDAC), Decitabine)

Completed
  • Acute Myeloid Leukemia
  • Birmingham, Alabama
  • +80 more
Feb 19, 2020

Acute Myeloid Leukemia Trial in United States (PLX3397)

Completed
  • Acute Myeloid Leukemia
  • San Francisco, California
  • +8 more
Feb 18, 2020

Acute Myeloid Leukemia, Multiple Myeloma, Diffuse Large B-cell Lymphoma Trial in France, Korea, Republic of, United States

Completed
  • Acute Myeloid Leukemia
  • +2 more
  • Los Angeles, California
  • +13 more
Feb 27, 2020

Home Away From Home - Medical Outcomes

Completed
  • Acute Myeloid Leukemia
  • +2 more
    • Little Rock, Arkansas
    • +16 more
    Dec 2, 2019

    Acute Myeloid Leukemia Trial in Canada, Germany, United States (Entospletinib, Daunorubicin, Cytarabine)

    Terminated
    • Acute Myeloid Leukemia
    • Los Angeles, California
    • +16 more
    Nov 13, 2019

    Acute Myeloid Leukemia Trial in Worldwide (Cytarabine or Supportive Care, Dacogen (decitabine) only)

    Completed
    • Acute Myeloid Leukemia
    • Cytarabine or Supportive Care
    • Dacogen (decitabine) only
    • Los Angeles, California
    • +107 more
    Aug 29, 2019

    Acute Myeloid Leukemia Trial in United States (IMGN779)

    Completed
    • Acute Myeloid Leukemia
    • Birmingham, Alabama
    • +6 more
    Sep 3, 2019

    Acute Myeloid Leukemia, MDS Trial in Boston (Prexasertib, Mitoxantrone, Etoposide)

    Terminated
    • Acute Myeloid Leukemia
    • Myelodysplastic Syndromes
    • Boston, Massachusetts
      Dana Farber Cancer Institute
    Jun 10, 2019

    Acute Myeloid Leukemia Trial in United States (Fludarabine, Melphalan, vadastuximab talirine)

    Terminated
    • Acute Myeloid Leukemia
    • Duarte, California
    • +10 more
    Dec 20, 2018

    Acute Myeloid Leukemia, Untreated Adult Acute Myeloid Leukemia Trial in Canada, United States (procedure, drug, other)

    Completed
    • Acute Myeloid Leukemia
    • Untreated Adult Acute Myeloid Leukemia
    • Allogeneic Hematopoietic Stem Cell Transplantation
    • +5 more
    • Birmingham, Alabama
    • +446 more
    Nov 28, 2018

    Acute Myeloid Leukemia Trial in Worldwide (33A, , azacitidine)

    Terminated
    • Acute Myeloid Leukemia
    • Little Rock, Arkansas
    • +127 more
    Nov 21, 2018

    Acute Myeloid Leukemia, Myelodysplastic Syndrome, Multiple Myeloma Trial in Boston (CM-CS1 T-cell infusion)

    Completed
    • Acute Myeloid Leukemia
    • +2 more
    • CM-CS1 T-cell infusion
    • Boston, Massachusetts
      Dana-Farber Cancer Institute
    May 30, 2018

    Acute Myeloid Leukemia Trial in United States (SGN-CD123A)

    Terminated
    • Acute Myeloid Leukemia
    • Birmingham, Alabama
    • +6 more
    May 8, 2018

    Acute Myeloid Leukemia, Acute Myelogenous Leukemia Trial in United States (Standard dose cytarabine for induction, SGN-CD33A,

    Completed
    • Acute Myeloid Leukemia
    • Acute Myelogenous Leukemia
    • Standard dose cytarabine for induction
    • +3 more
    • Birmingham, Alabama
    • +12 more
    May 8, 2018

    Acute Myeloid Leukemia, MDS Trial in Boston, New York (RO6870810)

    Completed
    • Acute Myeloid Leukemia
    • Myelodysplastic Syndromes
    • Boston, Massachusetts
    • +1 more
    Dec 7, 2017

    MRD Testing Before and After Hematopoietic Cell Transplantation

    Completed
    • Acute Myeloid Leukemia
      • Birmingham, Alabama
      • +37 more
      Sep 5, 2017